Bipolar Comprehensive Outcomes Study (BCOS)
The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year observational study designed to explore the clinical and functional outcomes associated with treatment of bipolar I or schizoaffective disorder. The sample comprises adults with a primary diagnosis of bipolar I disorder (manic, mixed or depressed episode) or schizoaffective disorder as defined by the DSM-IV-TR. In addition, all participants have a prescription for at least one of the following mood stabilisers at baseline — olanzapine, lithium carbonate, sodium valproate or carbamazepine.
Study design
Cohort - clinical
Number of participants at first data collection
240 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2005
Primary Institutions
Eli Lilly Australia
Mental Health Research Institute
Monash Alfred Psychiatry Research Centre
Orygen Research Centre
University of Melbourne
Links
No website available
Profile paper DOI
Funders
Eli Lilly Australia
Ongoing?
No
Data types collected
- Interview – face-to-face
- Secondary data
- Self-report questionnaire – paper or computer assisted
- None
- None
- Healthcare data
Engagement
Keywords
